Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes. | BMC Med | 2022 | 35341481 | PubTator, text mining | PubMed |
| CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach. | J Pers Med | 2022 | 35330393 | PubTator, text mining | PubMed |
| CRISPR/Cas: A New Tool in the Research of Telomeres and Telomerase as Well as a Novel Form of Cancer Therapy. | Int J Mol Sci | 2022 | 35328421 | PubTator, text mining | PubMed |
| Recombination Mediator Proteins: Misnomers That Are Key to Understanding the Genomic Instabilities in Cancer. | Genes (Basel) | 2022 | 35327990 | PubTator, text mining | PubMed |
| G-Quadruplex Matters in Tissue-Specific Tumorigenesis by BRCA1 Deficiency. | Genes (Basel) | 2022 | 35327946 | PubTator, text mining | PubMed |
| The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. | Biomolecules | 2022 | 35327559 | PubTator, text mining | PubMed |
| Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions. | Cancers (Basel) | 2022 | 35326655 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Inheritance at Telomeres. | Epigenomes | 2022 | 35323213 | PubTator, text mining | PubMed |
| PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth. | BMC Cancer | 2022 | 35321693 | PubTator, text mining | PubMed |
| Expression of BRCA1, BRCA2, RAD51, and other DSB repair factors is regulated by CRL4WDR70. | DNA Repair (Amst) | 2022 | 35316728 | PubTator, text mining | PubMed |
| Role of Paralogue of XRCC4 and XLF in DNA Damage Repair and Cancer Development. | Front Immunol | 2022 | 35309348 | PubTator, text mining | PubMed |
| The advances in nanomedicine for bone and cartilage repair. | J Nanobiotechnology | 2022 | 35303876 | PubTator, text mining | PubMed |
| Rejuvenation of Tissue Stem Cells by Intrinsic and Extrinsic Factors. | Stem Cells Transl Med | 2022 | 35303745 | PubTator, text mining | PubMed |
| Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. | Toxicology | 2022 | 35301059 | PubTator, text mining | PubMed |
| Retinoic Acid-Induced 2 (RAI2) Is a Novel Antagonist of Wnt/β-Catenin Signaling Pathway and Potential Biomarker of Chemosensitivity in Colorectal Cancer. | Front Oncol | 2022 | 35299743 | PubTator, text mining | PubMed |
| Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys. | Front Endocrinol (Lausanne) | 2022 | 35295987 | PubTator, text mining | PubMed |
| Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations. | Clin Cancer Res | 2022 | 35294533 | PubTator, text mining | PubMed |
| Universally Accessible Structural Data on Macromolecular Conformation, Assembly, and Dynamics by Small Angle X-Ray Scattering for DNA Repair Insights. | Methods Mol Biol | 2022 | 35290631 | PubTator, text mining | PubMed |
| Regulation of Lipid Metabolism by Lamin in Mutation-Related Diseases. | Front Pharmacol | 2022 | 35281936 | PubTator, text mining | PubMed |
| Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy. | Clin Sci (Lond) | 2022 | 35274136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=32